Decheng Capital is a venture capital firm that provides capital to early and growth stage life science companies in China. They are a team of investment professionals with complementary expertise, a long history of working together and a shared dedication to building successful companies that span the full spectrum of the life sciences industry. Their domain knowledge, access to innovative technologies and ability to bring proven Western products to China make them the preferred partner for entrepreneurs, domestic and multinational companies, government agencies and investors.
Decheng Capital is located in Shanghai and Silicon Valley and founded in 2012. With over $1 billion in capital under management, Decheng is poised to deliver returns for our investors and create value for our entrepreneur partners.
Decheng Capital's investments include Mynosys Cellular Devices, Hummingbird Bioscience, AnHeart Therapeutics, Baoyuan Biomedical, Bioheng, Luckin Coffee, Terns Pharmaceuticals, Polares Medical and Mindstrong Health.
Their exited investments include Invitae, Luckin Coffee, Arcus Biosciences, ARMO BioSciences, GeneWEAVE and SentreHEART.
Timeline
Funded Companies
Mount Sinai Genomics is a Connecticut-based medical genetics practice at the Mount Sinai Health System.
Mammoth Biosciences is an American company based in San Francisco founded on June 1, 2017. Mammoth Biosciences uses CRISPR technology to develop bio-sensing technologies for diagnostics in industries such as healthcare, agriculture, manufacturing, and forensics.
A company developing DNA sequencing technologies and systems
Cue Health is a San Diego-based medical device company working to track health information at the molecular level.
Omniome is a San Diego-based company.
ARMO BioSciences was a Redwood City, California-based biotechnology company.
Mammoth Diagnostics is a Brisbane, California-based company founded by Jennifer Doudna, Ashley Tehranchi, Trevor Martin, Janice Chen and Lucas Harrington.
A biopharmaceutical company developing antibodies for cancer, inflammatory diseases and ophthalmic diseases
GeneWEAVE is a manufacturer and supplier of clinical diagnostic solutions.
Encodia is a company founded in 2015.
Armo Bio Sciences is a Redwood City, California-based company.
Associated investment funds
People
Aaron Li, MBA
Associate
Clair Chin, M.D., MBA
Associate
Dan Zabrowski, Ph.D.
Venture Partner
Katherine Xu, Ph.D.
Partner
Min Cui, Ph.D.
Managing Director
Nick Pliam, M.D., Ph.D.
Partner
Peter Colabuono
Principal
Qiang Xu, Ph.D.
Partner
Tony Tong, Ph.D.
Principal
Victor E. Tong, Jr.
Partner
Wei Xu
Partner
Yang Lu, MBA
Associate
